Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Titel:
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
Auteur:
Ryan, Pablo Blanco, José L Masia, Mar Garcia-Fraile, Lucio Crusells, Maria J Domingo, Pere Curran, Adrian Guerri-Fernandez, Roberto Bernal, Enrique Bravo, Joaquin Revollo, Boris Macias, Juan Tiraboschi, Juan M Montejano, Rocio Amador, Concepción Torralba, Miguel Merino, Dolores Diaz-Brito, Vicens Galindo, M J Ferra, Sergio Villoslada, Aroa Losa, Juan Emilio Fanjul, Francisco J Perez-Stachowski, Xavier Peraire, Joaquim Portilla, Joaquin de la Fuente, Sara Dueñas, Carlos Vazquez, Maria J Di Gregorio, Silvana Esteban, Herminia Gil, Pedro de Miguel, Marta Alejos, Belen Martínez, Esteban